Our ORCID 0000-0002-3997-2355
2021
Jarazo J., Barmpa K., Modamio J., Saraiva C., Sabaté S, Rosety I., Griesbeck A., Skwirblies F., Zaffaroni G., Smits L., Su J., Arias J., Walter J., Gomez G., Monzel A., Qing X., Vitali A., Cruciani G, Boussaad I., Brunelli F., Jäger C., Rakovic A., Li W., Yuan L., Berger E., Arena G. , Bolognin S., Schmidt R., Schröder C., Antony P., Klein C., Krüger R., Seibler P., Schwamborn J. (2021). "Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment"
Mov Disord. doi:10.1002/mds.28810. article
Arias J., Yu J., Varshney M., Inzunza J., Nalvarte I. (2021). "HSC and iPS cell‐derived CAR‐NK cells as reliable cell‐based therapy solutions". Stem cell Tra Med. doi:10.1002/sctm.20-0459. article
2020
Inzunza J., Arias J., Segura-Aguilar J., Nalvarte I., Varshney M. (2020). "Generation of nonviral integration-free human iPS cell line KISCOi001-A from normal human fibroblasts, under defined xeno-free and feeder-free conditions." Stem Cell Res. doi:10.1016/j.scr.2021.102193. article
Barbuti P., Antony P., Santos B., Massart F., Cruciani G., Dording C., Arias J., Schwamborn J., Krüger R. (2020). "Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess alpha-synuclein with Familial Parkinson’s Disease Point Mutation A30P". Cells. doi:10.3390/cells9092065 article
2019
Gomez-Giro, G., Arias J., Schöler, Hans, et al. (2019). "Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis." Acta Neuropathol Commun. doi:10.1186/s40478-019-0871-7. article
Arias J. et al. (2019). "Generation of human induced pluripotent stem cell lines from patients with selective IgA deficiency." Stem Cell Res. doi:10.1016/j.scr.2019.101613. article
Arias J. et al. (2019). "Generation of a human induced pluripotent stem cell line (PHAi003) from a primary immunodeficient patient with CD70 mutation." Stem Cell Res. doi:10.1016/j.scr.2019.101612. article
Nie M., Du L., Zhang B., Ren W., Joung J., Ye X., Arias J., Shi X., Liu D., Wu K., Zhang F., et al. Essentiality of CREBBP in EP300 truncated B-cell lymphoma revealed by genome-wide CRISPR Cas9 screen. Biorxiv. (2019). doi:10.1101/746594 article
2018
Arias J. et al., (2018.) "Automated high-throughput high-content autophagy and mitophagy phenotyping in Parkinson's disease." Sci Rep doi:10.1101/412957. article
Walter, J., Arias, J. et al. (2018). "Neural stem cells of Parkinson's Disease patients exhibit aberrant mitochondrial morphology and functionality." Stem Cell Reports. doi:10.1016/j.stemcr.2019.03.004. article
2017
Arias J., Schöler, Hans, et al., (2017). "FACS-assisted CRISPR Cas9 genome editing facilitates Parkinson's disease modeling." Stem Cell Reports. doi:10.1016/j.stemcr.2017.08.026. article
Qing X., Arias J., et al. (2017). "CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2- G2019S knock-in reveals neuronal complexity phenotypes and alpha-synuclein modulation in dopaminergic neurons." Stem Cell Res. doi:10.1016/j.scr.2017.08.013. article